| 25 May 2026 |
Dianabol |
6.2 |
100mg |
114.5mg |
+14.5% |
96.98% |
Lab F |
| 24 May 2026 |
Primobolan Oral (Methenolone Acetate) |
5.7 |
10mg |
12.4mg |
+24.4% |
98.15% |
Lab B |
| 24 May 2026 |
Thymosin Alpha-1 |
8.5 |
15mg |
15.4mg |
+2.8% |
95.64% |
Lab C |
| 24 May 2026 |
DNP |
6.0 |
25mg |
21.3mg |
-14.7% |
95.52% |
Lab D |
| 24 May 2026 |
Anadrol (Oxymetholone) |
9.9 |
20mg |
24.8mg |
+24.2% |
96.41% |
Lab G |
| 24 May 2026 |
HCG |
9.7 |
30mg |
34.0mg |
+13.3% |
95.23% |
Lab G |
| 24 May 2026 |
BAM15 |
6.8 |
20mg |
21.0mg |
+5.0% |
99.72% |
Lab D |
| 23 May 2026 |
Dihexa |
5.5 |
100mg |
90.3mg |
-9.7% |
98.15% |
Lab E |
| 21 May 2026 |
APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 |
5.0 |
1g |
0.9g |
-5.2% |
95.34% |
Lab D |
| 21 May 2026 |
Pinealon |
4.4 |
30mg |
33.1mg |
+10.3% |
95.06% |
Lab E |
| 21 May 2026 |
Testosterone Phenylpropionate Raw |
9.4 |
5g |
4.6g |
-8.3% |
95.07% |
Lab B |
| 21 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
5.0 |
15mg |
14.1mg |
-6.2% |
97.40% |
Lab A |
| 21 May 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
9.6 |
20mg |
22.8mg |
+13.9% |
96.38% |
Lab A |
| 21 May 2026 |
HGH Fragment 176-191 |
5.7 |
30mg |
33.2mg |
+10.5% |
95.88% |
Lab E |
| 19 May 2026 |
Alprostadil |
8.5 |
2mg |
2.0mg |
+0.5% |
95.82% |
Lab E |
| 17 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
5.3 |
10mg |
10.5mg |
+4.9% |
96.02% |
Lab D |
| 17 May 2026 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
6.4 |
20mg |
20.8mg |
+3.8% |
98.10% |
Lab B |
| 26 Jan 2026 |
4-Piperidone CAS 41661-47-6 |
6.5 |
100g |
111.5g |
+11.5% |
97.13% |
Lab C |
| 26 Jan 2026 |
ACE-031 |
7.3 |
50mg |
55.5mg |
+11.1% |
98.91% |
Lab B |
| 9 Jan 2026 |
DSIP |
7.9 |
15mg |
17.7mg |
+18.0% |
96.71% |
Lab F |
| 9 Jan 2026 |
SS-31 |
8.1 |
20mg |
23.0mg |
+14.8% |
97.08% |
Lab D |
| 7 Jan 2026 |
NPP |
5.9 |
250mg/ml |
238.2mg/ml |
-4.7% |
96.32% |
Lab A |
| 6 Jan 2026 |
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) |
9.8 |
300mg/ml |
309.4mg/ml |
+3.1% |
98.64% |
Lab E |
| 6 Jan 2026 |
LL37 |
5.9 |
20mg |
18.9mg |
-5.3% |
95.48% |
Lab C |
| 29 Dec 2025 |
Retatrutide |
4.3 |
30mg |
32.9mg |
+9.7% |
98.67% |
Lab E |
| 13 Dec 2025 |
Retatrutide |
4.1 |
30mg |
25.3mg |
-15.7% |
99.30% |
Lab G |
| 13 Dec 2025 |
Retatrutide |
7.5 |
60mg |
62.7mg |
+4.5% |
99.70% |
Lab G |
| 12 Dec 2025 |
4-Anilinopiperidine CAS 99918-43-1 |
6.0 |
100g |
106.8g |
+6.8% |
98.80% |
Lab A |
| 6 Dec 2025 |
Retatrutide |
7.7 |
20mg |
20mg |
|
99.77% |
Lab E |
| 5 Dec 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
5.5 |
5mg |
4.8mg |
-3.9% |
97.09% |
Lab A |
| 5 Dec 2025 |
Tesofensine |
6.4 |
25mg |
25.4mg |
+1.6% |
96.73% |
Lab E |
| 23 Nov 2025 |
LGD-4033 (Ligandrol) |
4.0 |
50mg |
56.7mg |
+13.4% |
95.04% |
Lab B |
| 17 Nov 2025 |
CJC-1295 With DAC |
10.0 |
2mg |
1.9mg |
-5.9% |
96.63% |
Lab D |
| 14 Nov 2025 |
EPO |
4.0 |
2mg |
2.1mg |
+5.6% |
95.79% |
Lab G |
| 14 Nov 2025 |
Testosterone Cypionate Raw |
7.4 |
10g |
12.0g |
+20.5% |
97.91% |
Lab A |
| 5 Nov 2025 |
Halotestin (Fluoxymesterone) |
6.0 |
100mg |
117.6mg |
+17.6% |
97.10% |
Lab A |
| 3 Oct 2025 |
Cerebrolysin |
6.6 |
20mg |
24.3mg |
+21.3% |
98.81% |
Lab F |
| 4 Sep 2025 |
Retatrutide |
9.9 |
20mg |
20.8mg |
+4.0% |
99.87% |
Lab E |
| 11 Aug 2025 |
Retatrutide |
8.0 |
30mg |
29mg |
-3.3% |
99.95% |
Lab E |